PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsmultiple myeloma
MeSH D009101 - multiple myeloma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008232:Lymphoproliferative disorders
2 Companies
2 Drugs
$
Success rate
D010265:Paraproteinemias
1 Company
1 Drug
$
Success rate
D020141:Hemostatic disorders
1 Company
1 Drug
$
Success rate
D054219:Plasma cell neoplasms
1 Company
1 Drug
$
Success rate
D009101: 
Multiple myeloma
83 Companies
34 Drugs
$
Success rate
D007952:Plasma cell leukemia
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Accord HealthcareBortezomib Bortezomib  2022-07-26   
Bortezomib Bortezomib Accord  2015-07-20   
Carmustine Carmustine  2022-12-27   
Lenalidomide Lenalidomide Accord  2018-09-20   
Zoledronic acid Zoledronic Acid  2016-11-28   
Zoledronic acid Zoledronic Acid Accord  2014-01-16   
Plerixafor Plerixafor Accord  2022-12-16   
Doxorubicin Zolsketil pegylated  2022-05-31   
Cisplatin Cisplatin  2015-08-18   
Acrotech BiopharmaMelphalan Evomela 2029-03-13 2016-03-10   
AdienneMelphalan Phelinun  2020-11-16   
Alembic PharmaceuticalsCyclophosphamide Cyclophosphamide  2022-11-10   
Carmustine Carmustine  2023-10-20   
AllerganMelphalan Melphalan  2016-12-19   
Zoledronic acid Zoledronic Acid  2013-03-04   
Zoledronic acid Zoledronic acid Actavis  2012-04-20   
AlvogenMelphalan Melphalan  2017-03-22   
AmgenCarfilzomib Kyprolis  2015-11-19 $1,503 M Y2024 
Amneal PharmaceuticalsCarmustine Carmustine  2018-10-16   
Cyclophosphamide Cyclophosphamide  2018-05-25   
Zoledronic acid Zoledronic Acid  2017-10-27   
Plerixafor Plerixafor  2023-07-24   
Lenalidomide Lenalidomide  2025-01-31   
ANI PharmaceuticalsCyclophosphamide Cyclophosphamide  2018-03-19   
ApotexMelphalan Alkeran  1982-01-01   
Bortezomib Bortezomib  2022-05-02   
Carfilzomib Carfilzomib  2020-03-16   
Lenalidomide Lenalidomide  2022-08-30   
Zoledronic acid Zoledronic Acid  2015-12-24   
Pomalidomide Pomalidomide  2024-06-11   
1
2
3
4
5
6
...
9
>
Clinical Trials
Historical Success Rate
Phase 1
76%
194/255
Phase 2
35%
96/272
Phase 3
47%
83/176
Approved: 52Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Accord Healthcare
Cisplatin
Acrotech Biopharma
Melphalan,
Sodium chloride
Allergan
Lornoxicam
Amgen
Carfilzomib,
Belantamab,
Mafodotin,
Docusate,
Tbo-filgrastim,
Vitamin e,
Iberdomide,
Aglatimagene besadenovec,
Lampalizumab,
Lenograstim,
Calcium dobesilate,
Doconexent,
Lornoxicam,
Terfenadine,
Molgramostim,
Afuresertib,
Aspartame,
Bevifimod,
Corticorelin,
MURIZATOCLAX,
Nepidermin,
OPROZOMIB,
PACANALOTAMAB,
PAVURUTAMAB,
Polyglycolic acid,
TAPOTOCLAX,
Microcrystalline cellulose,
Pamidronic acid,
Retinol,
Amg531,
Corticoids,
Foster,
Caelyx,
Doxorubin,
Vp16,
Solumedrol,
Hydroxydaunomycin,
Cc5013,
Rhuepo,
Sominex
Baxter
Doxorubicin,
Cyclophosphamide,
Doxorubicin hydrochloride,
Caelyx,
Doxorubin,
Hydroxydaunomycin
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use